Jing Feng
Nurse Practitioner, Greenlane Clinical Centre ORL Service, Auckland, NZ
|
Jing Feng is a Nurse Practitioner who works at Greenlane Clinical Centre ORL service. She has been in the service for nine years and completed her Master’s degree in Nursing before qualifying as a Nurse Practitioner in 2025.
Jing currently leads nurse-led otology clinics, managing a wide range of presentations including acute and chronic ear conditions. She is actively working to expand her scope of practice to further enhance access to specialist ORL care. She is involved in the Ear Nurse Specialist Group, contributing to the development of a knowledge and skills framework, and is currently assisting to develop an online otology course aimed at supporting the wider community ear nurses and other healthcare professionals involved in ear assessment. Jing is passionate about delivering holistic, patient-centred care with a strong focus on health promotion. Her work also reflects a commitment to innovative models of care that improve patient access and experience. At this conference, Jing will present on the NF2/Skull Base multidisciplinary meeting (MDM), highlighting the importance of coordinated, wrap-around care for patients with this rare but life-impacting condition. The MDM model aims to reduce fragmented care, minimise multiple clinic visits, and improve overall patient outcomes through a collaborative approach. |
|
NF2-Related Schwannomatosis
Introduction
NF2-related schwannomatosis is a rare genetic disorder characterised by the development of multiple schwannomas, meningiomas, and ependymomas. Delayed recognition is common due to its variable clinical presentation, resulting in missed opportunities for early intervention and coordinated multidisciplinary care.
Aim
This presentation aims to increase awareness of NF2-related schwannomatosis by reviewing its clinical presentation, current diagnostic criteria, and principles of management. It also highlights the important role of clinicians in recognising early features and facilitating timely referral.
Content
Common presenting symptoms, including progressive hearing loss, tinnitus, balance disturbance, cranial and peripheral neuropathies, and multiple nerve sheath tumours, will be discussed alongside the updated diagnostic criteria incorporating clinical, radiological, and genetic findings. Contemporary management strategies, including surveillance, surgery, targeted therapies, hearing rehabilitation, and multidisciplinary care, will be reviewed. The presentation emphasises practical approaches that can be implemented across a range of healthcare settings.
Conclusion
Although NF2-related schwannomatosis is a complex condition requiring lifelong monitoring and specialist input, the pathway to diagnosis and ongoing care does not need to be complicated. Increasing clinician awareness, recognising key clinical features, and adopting clear referral and management pathways can improve diagnostic timeliness, optimise patient outcomes, and ensure individuals receive coordinated, patient-centred care.
NF2-related schwannomatosis is a rare genetic disorder characterised by the development of multiple schwannomas, meningiomas, and ependymomas. Delayed recognition is common due to its variable clinical presentation, resulting in missed opportunities for early intervention and coordinated multidisciplinary care.
Aim
This presentation aims to increase awareness of NF2-related schwannomatosis by reviewing its clinical presentation, current diagnostic criteria, and principles of management. It also highlights the important role of clinicians in recognising early features and facilitating timely referral.
Content
Common presenting symptoms, including progressive hearing loss, tinnitus, balance disturbance, cranial and peripheral neuropathies, and multiple nerve sheath tumours, will be discussed alongside the updated diagnostic criteria incorporating clinical, radiological, and genetic findings. Contemporary management strategies, including surveillance, surgery, targeted therapies, hearing rehabilitation, and multidisciplinary care, will be reviewed. The presentation emphasises practical approaches that can be implemented across a range of healthcare settings.
Conclusion
Although NF2-related schwannomatosis is a complex condition requiring lifelong monitoring and specialist input, the pathway to diagnosis and ongoing care does not need to be complicated. Increasing clinician awareness, recognising key clinical features, and adopting clear referral and management pathways can improve diagnostic timeliness, optimise patient outcomes, and ensure individuals receive coordinated, patient-centred care.
